Biohaven Ltd’s recent filing unveils that its Director CHILDS JOHN W acquired Company’s shares for reported $1.0 million on Mar 04 ’25. In the deal valued at $30.47 per share,32,700 shares were bought. As a result of this transaction, CHILDS JOHN W now holds 2,320,571 shares worth roughly $34.21 million.
Then, CHILDS JOHN W bought 29,000 shares, generating $1,042,393 in total proceeds. Upon buying the shares at $35.94, the Director now owns 2,368,741 shares.
Before that, CHILDS JOHN W bought 21,052 shares. Biohaven Ltd shares valued at $999,970 were divested by the Director at a price of $47.50 per share. As a result of the transaction, CHILDS JOHN W now holds 21,052 shares, worth roughly $0.31 million.
RBC Capital Mkts downgraded its Biohaven Ltd [BHVN] rating to a Sector perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid February with a ‘”a Buy”‘ rating. Jefferies began covering BHVN with “Buy” recommendation on September 16, 2024. Bernstein started covering the stock on September 04, 2024. It rated BHVN as “an Outperform”.
Price Performance Review of BHVN
On Friday, Biohaven Ltd [NYSE:BHVN] saw its stock fall -3.22% to $14.74. Over the last five days, the stock has gained 0.20%. Biohaven Ltd shares have fallen nearly -58.73% since the year began. Nevertheless, the stocks have fallen -60.54% over the past one year.
The most recent change occurred on July 24, 2024 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $58 price target.
